Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |